IOMMELLI, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 45
NA - Nord America 39
EU - Europa 26
Totale 110
Nazione #
SG - Singapore 35
US - Stati Uniti d'America 33
IT - Italia 24
KR - Corea 9
CA - Canada 6
RU - Federazione Russa 2
CN - Cina 1
Totale 110
Città #
Singapore 32
Naples 18
Santa Clara 11
Seoul 9
Belleville 6
Boardman 5
Moscow 2
Atena Lucana 1
Aversa 1
Boves 1
Forest City 1
Guangzhou 1
Totale 88
Nome #
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 11
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art 10
Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC 8
Novel and selective αvβ3 receptor peptide antagonist: Design, synthesis, and biological behavior 7
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 6
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 6
A reversible shift of driver dependence from egfr to notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 6
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 6
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 5
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer 4
Early F-18-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 4
[18]F-FLT PET-CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC. 4
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 3
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer. 3
18F-FLT PET/CT to guide therapy with EGFR antagonists and Bcl-xL inhibitors in non-small cell lung cancer. 3
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 3
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 3
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 2
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 2
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 2
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 2
Notch1-dependent targets in cancer stem cell resistance to EGFR inhibitors in oncogene-driven non-small cell lung cancer 2
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 2
PET/CT in cancer research: from preclinical to clinical applications 2
99mTc-MIBI in the evaluation of breast cancer biology 2
Preclinical Imaging in Targeted Cancer Therapies 2
Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation. 2
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer 2
99mTc-MIBI in the evaluation of breast cancer biology 2
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC 2
New and selective radiolabeled alpha(v)beta(3) antagonist as tracer in tumor diagnosis 1
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 1
Imaging of alpha(v)beta(3) Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with alpha(v)beta(5) 1
IN VIVO IMAGING OF ALPHA(V)BETA(3) INTEGRIN EXPRESSION WITH A RADIOLABELED CHIMERIC RDG PEPTIDE 1
PET/CT in cancer research: from preclinical to clinical applications 1
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer 1
A RADIOLABELING SYNTHESIS OF RGD ECHI WITH 18FLUORIDE- 1
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells 1
Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT 1
18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors 1
Preclinical imaging for targeting cancer immune evasion 1
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 1
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 1
18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 1
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins 1
Evaluation of experimental pulmonary metastases in murine models by x-ray micro-computed tomography 1
Molecular imaging of tumor microenvironment: challenges and perspectives 1
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 1
In vivo imaging of alpha(v)beta(3) integrin expression with a radiolabeled chimeric RGD peptide 1
Preclinical imaging in oncology: advances and perspectives 1
Stato dell'arte dell'imaging preclinico in oncologia 1
18F-FLT PET/CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC 1
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior. 1
Molecular imaging of drug resistance in cancer 1
Totale 142
Categoria #
all - tutte 1.065
article - articoli 848
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 19
Totale 1.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202446 0 0 0 0 0 0 0 0 4 13 14 15
2024/202596 14 13 69 0 0 0 0 0 0 0 0 0
Totale 142